Paskalis H[au] - Search Results

Year	Number of Results
1985	1
1986	2
2013	1
2016	2
2022	1
2023	1
2024	0

1

Changes in the risk profile and outcomes of patients undergoing isolated coronary artery bypass grafting: A 23-year analysis of over 14000 patients.

Pattakos G, Siminelakis S, Apostolakis E, Paskalis H, Goudevenos I. Pattakos G, et al. Among authors: paskalis h. Hellenic J Cardiol. 2023 Jan-Feb;69:64-66. doi: 10.1016/j.hjc.2022.09.011. Epub 2022 Sep 29. Hellenic J Cardiol. 2023. PMID: 36184033 Free article. No abstract available.

2

Expression and characterization of the trans-activator of HTLV-III/LAV virus.

Wright CM, Felber BK, Paskalis H, Pavlakis GN. Wright CM, et al. Among authors: paskalis h. Science. 1986 Nov 21;234(4779):988-92. doi: 10.1126/science.3490693. Science. 1986. PMID: 3490693

3

Challenge for higher colistin dosage in critically ill patients receiving continuous venovenous haemodiafiltration.

Karaiskos I, Friberg LE, Galani L, Ioannidis K, Katsouda E, Athanassa Z, Paskalis H, Giamarellou H. Karaiskos I, et al. Among authors: paskalis h. Int J Antimicrob Agents. 2016 Sep;48(3):337-41. doi: 10.1016/j.ijantimicag.2016.06.008. Epub 2016 Jul 18. Int J Antimicrob Agents. 2016. PMID: 27474468

4

Concentration-related mydriasis in a patient with renal dysfunction treated with phenytoin.

Ioannidis K, Papachristos A, Athanassa Z, Skarlatinis I, Paskalis H. Ioannidis K, et al. Among authors: paskalis h. Hippokratia. 2016 Apr-Jun;20(2):166-168. Hippokratia. 2016. PMID: 28416916 Free PMC article.

5

The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats.

Felber BK, Paskalis H, Kleinman-Ewing C, Wong-Staal F, Pavlakis GN. Felber BK, et al. Among authors: paskalis h. Science. 1985 Aug 16;229(4714):675-9. doi: 10.1126/science.2992082. Science. 1985. PMID: 2992082

6

Successful treatment of extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis with intraventricular colistin after application of a loading dose: a case series.

Karaiskos I, Galani L, Baziaka F, Katsouda E, Ioannidis I, Andreou A, Paskalis H, Giamarellou H. Karaiskos I, et al. Among authors: paskalis h. Int J Antimicrob Agents. 2013 May;41(5):480-3. doi: 10.1016/j.ijantimicag.2013.02.010. Epub 2013 Apr 6. Int J Antimicrob Agents. 2013. PMID: 23566531

7

Cis-acting sequences responsible for the transcriptional activation of human T-cell leukemia virus type I constitute a conditional enhancer.

Paskalis H, Felber BK, Pavlakis GN. Paskalis H, et al. Proc Natl Acad Sci U S A. 1986 Sep;83(17):6558-62. doi: 10.1073/pnas.83.17.6558. Proc Natl Acad Sci U S A. 1986. PMID: 3018737 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

7 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year